Catalyst Biosciences Price History

CBIODelisted Stock  USD 0.41  0.02  4.65%   
If you're considering investing in Catalyst Stock, it is important to understand the factors that can impact its price. As of today, the current price of Catalyst Biosciences stands at 0.41, as last reported on the 27th of November, with the highest price reaching 0.44 and the lowest price hitting 0.40 during the day. We have found twenty-nine technical indicators for Catalyst Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Catalyst Biosciences' Risk Adjusted Performance of 0.1384, downside deviation of 6.83, and Mean Deviation of 4.25 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Catalyst Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CBIO
Based on monthly moving average Catalyst Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Catalyst Biosciences by adding Catalyst Biosciences to a well-diversified portfolio.

Catalyst Biosciences Stock Price History Chart

There are several ways to analyze Catalyst Stock price data. The simplest method is using a basic Catalyst candlestick price chart, which shows Catalyst Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Catalyst Stock Price History Data

The price series of Catalyst Biosciences for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 0.25 with a coefficient of variation of 24.79. The prices are distributed with arithmetic mean of 0.27. The median price for the last 90 days is 0.24. The company had 1:15 stock split on 13th of February 2017. Catalyst Biosciences issued dividends on 2023-01-13.
OpenHighLowCloseVolume
11/27/2024
 0.43  0.44  0.40  0.41 
07/24/2023 0.43  0.44  0.40  0.41  296,416 
07/21/2023 0.42  0.46  0.41  0.43  571,687 
07/20/2023 0.39  0.42  0.39  0.41  374,199 
07/19/2023 0.46  0.48  0.36  0.37  1,173,848 
07/18/2023 0.44  0.46  0.43  0.45  789,165 
07/17/2023 0.39  0.41  0.39  0.41  512,832 
07/14/2023 0.35  0.39  0.35  0.38  355,102 
07/13/2023 0.35  0.36  0.35  0.35  133,285 
07/12/2023 0.34  0.35  0.34  0.34  165,723 
07/11/2023 0.34  0.36  0.34  0.35  181,526 
07/10/2023 0.36  0.37  0.35  0.36  207,798 
07/07/2023 0.35  0.36  0.34  0.35  198,600 
07/06/2023 0.34  0.35  0.32  0.34  228,710 
07/05/2023 0.35  0.36  0.33  0.34  354,294 
07/03/2023 0.37  0.37  0.34  0.35  249,800 
06/30/2023 0.35  0.36  0.34  0.35  223,348 
06/29/2023 0.35  0.36  0.34  0.34  250,608 
06/28/2023 0.34  0.35  0.33  0.34  424,197 
06/27/2023 0.31  0.34  0.31  0.33  525,342 
06/26/2023 0.30  0.33  0.29  0.31  340,758 
06/23/2023 0.30  0.32  0.29  0.30  756,539 
06/22/2023 0.35  0.37  0.31  0.32  1,666,415 
06/21/2023 0.31  0.50  0.30  0.35  16,149,497 
06/20/2023 0.29  0.30  0.27  0.29  1,097,815 
06/16/2023 0.27  0.28  0.26  0.26  595,311 
06/15/2023 0.24  0.26  0.24  0.25  323,897 
06/14/2023 0.24  0.24  0.23  0.23  195,052 
06/13/2023 0.24  0.24  0.23  0.23  121,483 
06/12/2023 0.24  0.24  0.22  0.23  120,382 
06/09/2023 0.23  0.24  0.22  0.23  63,760 
06/08/2023 0.25  0.25  0.22  0.22  197,783 
06/07/2023 0.24  0.25  0.24  0.24  96,947 
06/06/2023 0.25  0.25  0.23  0.23  102,332 
06/05/2023 0.25  0.25  0.23  0.24  173,591 
06/02/2023 0.22  0.24  0.22  0.23  350,596 
06/01/2023 0.24  0.24  0.21  0.21  302,780 
05/31/2023 0.24  0.24  0.22  0.22  162,657 
05/30/2023 0.23  0.24  0.23  0.23  332,159 
05/26/2023 0.24  0.24  0.22  0.23  50,277 
05/25/2023 0.24  0.24  0.22  0.22  115,344 
05/24/2023 0.23  0.24  0.22  0.23  39,035 
05/23/2023 0.24  0.24  0.22  0.23  425,287 
05/22/2023 0.24  0.24  0.23  0.24  66,385 
05/19/2023 0.24  0.24  0.23  0.23  57,191 
05/18/2023 0.22  0.24  0.22  0.23  174,255 
05/17/2023 0.23  0.24  0.23  0.23  65,733 
05/16/2023 0.24  0.24  0.23  0.23  151,845 
05/15/2023 0.22  0.23  0.22  0.22  97,600 
05/12/2023 0.22  0.23  0.22  0.22  77,108 
05/11/2023 0.22  0.24  0.22  0.23  364,371 
05/10/2023 0.22  0.23  0.22  0.22  120,732 
05/09/2023 0.22  0.23  0.21  0.21  209,256 
05/08/2023 0.22  0.22  0.21  0.21  114,894 
05/05/2023 0.21  0.22  0.21  0.21  24,250 
05/04/2023 0.21  0.24  0.21  0.22  163,404 
05/03/2023 0.21  0.22  0.21  0.21  134,825 
05/02/2023 0.21  0.22  0.20  0.21  43,540 
05/01/2023 0.22  0.22  0.20  0.20  133,927 
04/28/2023 0.22  0.24  0.21  0.21  190,577 
04/27/2023 0.23  0.23  0.22  0.23  116,005 

About Catalyst Biosciences Stock history

Catalyst Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Catalyst is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Catalyst Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Catalyst Biosciences stock prices may prove useful in developing a viable investing in Catalyst Biosciences
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California. Catalyst Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.

Catalyst Biosciences Stock Technical Analysis

Catalyst Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Catalyst Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Catalyst Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

Catalyst Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Catalyst Biosciences' price direction in advance. Along with the technical and fundamental analysis of Catalyst Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Catalyst to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Catalyst Stock

If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings